Aperio Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Aperio Group’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-32,305	Closed	-$548K	–	2041
2014 Q4	$548K	Buy	+32,305	New	+$454K	0.01%	1174

Aperio Group's AVNR Position: Q1 2015 in Review

Aperio Group sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 32,305 shares — an estimated $548K sold.

Aperio Group first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $548K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Aperio Group reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Aperio Group sold 32,305 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $548K.
Aperio Group first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
Aperio Group's AVANIR PHARMACEUTICALS, INC CL A position peaked at $548K in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Aperio Group's 13F filing for Q1 2015, filed 29 Apr 2015.